Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.
about
The streptococcal collagen-like protein-1 (Scl1) is a significant determinant for biofilm formation by group a StreptococcusThe group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissueCrystal Structure of Peroxide Stress Regulator from Streptococcus pyogenes Provides Functional Insights into the Mechanism of Oxidative Stress SensingNatural variant of collagen-like protein a in serotype M3 group a Streptococcus increases adherence and decreases invasive potentialDispersal of Group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine modelIdentification of Rgg-regulated exoproteins of Streptococcus pyogenes.Insight into the molecular basis of pathogen abundance: group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into human cellsMosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes.Membrane damage elicits an immunomodulatory program in Staphylococcus aureusA combination of independent transcriptional regulators shapes bacterial virulence gene expression during infectionNADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates.Growth characteristics of and virulence factor production by group A Streptococcus during cultivation in human salivaIdentification and characterization of the scl gene encoding a group A Streptococcus extracellular protein virulence factor with similarity to human collagen.Identification and immunogenicity of group A Streptococcus culture supernatant proteinsIdentification and characterization of a second extracellular collagen-like protein made by group A Streptococcus: control of production at the level of translation.Genome-wide essential gene identification in Streptococcus sanguinis.Srv mediated dispersal of streptococcal biofilms through SpeB is observed in CovRS+ strainsCentral role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human salivaIdentification and characterization of a novel heme-associated cell surface protein made by Streptococcus pyogenesStreptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozymeGroup A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.Opsonophagocytosis-inhibiting mac protein of group a streptococcus: identification and characteristics of two genetic complexesSequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway.Disease manifestations and pathogenic mechanisms of Group A Streptococcus.The small regulatory RNA FasX enhances group A Streptococcus virulence and inhibits pilus expression via serotype-specific targets.Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenesGenome-wide gene deletions in Streptococcus sanguinis by high throughput PCR.Proteolysis and its regulation at the surface of Streptococcus pyogenes.Partial loss of CovS function in Streptococcus pyogenes causes severe invasive diseaseRivR and the small RNA RivX: the missing links between the CovR regulatory cascade and the Mga regulon.Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins.Subversion of the innate immune response by micro-organisms.drs (Distantly related sic) gene polymorphisms among emm12-type Streptococcus pyogenes isolatesMaltodextrin utilization plays a key role in the ability of group A Streptococcus to colonize the oropharynxIdentification of rocA, a positive regulator of covR expression in the group A streptococcus.Niche-specific contribution to streptococcal virulence of a MalR-regulated carbohydrate binding protein.Analysis of the transcriptome of group A Streptococcus in mouse soft tissue infectionStreptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 group A StreptococcusRegulation of polysaccharide utilization contributes to the persistence of group a streptococcus in the oropharynx.
P2860
Q23913487-8453FD38-933F-46B4-A748-78BA70A48442Q23913488-AF7E641B-C528-47C8-AA92-1387FB85D824Q27677996-D812A464-F9FB-4C0D-9064-15D42C8552E6Q28388079-7D62D0E4-79A0-4855-8BFD-02F895D771CAQ28477890-D118E288-279D-43B6-9A25-3706B9D81C4FQ30658605-74D675CB-C63B-4334-A8BD-83AC5AB4D5BAQ30732369-AB33E966-18D8-437A-9E9B-5BFD5E66864DQ33214624-8FA53445-38D1-4D70-B197-1B12E09F8475Q33543122-5189D04B-F870-46B8-9E03-2BBADBCE1FCFQ33545217-82442234-1A14-4D2A-8D67-9A22C33EC23AQ33578435-193C60AF-F064-4C5F-85E9-0F015E2B79C4Q33946900-C9908BF6-5D31-4E59-BB78-667433B619AFQ34005105-33085251-7EE2-44B9-B535-1A0FC5C9C1B4Q34005223-6514EF45-DDB4-4CEE-BA14-D797CB82D034Q34006462-F80429AC-0486-4F6B-B090-2ADB5FE4AB4DQ34030793-9BDE0346-9C89-453F-84E9-4D54D71C9147Q34098283-32994B4C-3B6B-4A07-B1A7-3FEEA795193FQ34115927-D5D2C2CD-109F-46B5-8EC7-B46433F235E0Q34127696-5ACD82EB-1E4B-49A2-ABB5-0D321EC966F0Q34130420-DCB96406-0C4C-4137-8DEE-01B0E99D074DQ34142091-0BF8BC91-C9CD-41D7-9A7D-A4AFF67AE3BAQ34260905-E80E89EC-2F16-44BD-A075-60CD758C79F5Q34369853-FEE33D4E-D452-4EC0-BC86-E9A11337AAC7Q34413457-BD94C734-8E7B-492A-B4C1-D1591D0116EFQ34458113-F2747D26-4938-461D-AF8B-80FBD2E26DF6Q34489004-674558C3-990C-494C-8392-B9B043531BA0Q34499020-35806FD8-651B-4663-8362-2AA6068000DCQ34585533-E38AB753-0448-40C9-AF80-B29D9557452BQ34640704-AABC36A6-A0E5-440C-8033-BCDC94AA7D1CQ34713892-7974BD2B-91C7-459C-B838-A3C9F5814BDEQ34876077-FD54EE6C-D6DE-41B5-8184-EB4A5FF99FD6Q34942251-16F76BAB-9524-48BC-9D4A-73AEBDE9E1D7Q34962956-11BF9D29-041E-47CC-A4F0-5D945E7A7231Q34974726-15A08CE1-00D2-4AF3-B822-57838CF990DEQ34975859-954D9BB2-97E2-429D-84D3-BA9F4DA2485CQ34977571-62ED1335-7101-445C-AB0F-D2C09672C393Q35138396-797ECABC-D6E7-49D2-9991-F5E860253FB9Q35222098-87B1A3D4-A57E-46F6-B8F2-5D776314E1A0Q35559866-46ACFA24-1B12-413E-8482-CE949441345DQ35913415-532FCCAD-8BBD-4AB1-87B6-07CFB948BB7C
P2860
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@ast
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@en
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene
@nl
type
label
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@ast
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@en
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene
@nl
prefLabel
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@ast
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@en
Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene
@nl
P2093
P2860
P1476
Nonpolar inactivation of the h ...... es mouse mucosal colonization.
@en
P2093
J M Musser
J Rurangirwa
S Lukomski
P2860
P304
P356
10.1128/IAI.68.2.535-542.2000
P407
P577
2000-02-01T00:00:00Z